Search results for "Constriction"

showing 10 items of 254 documents

In vivo antihypertensive mechanism of lactoferrin-derived peptides: Reversion of angiotensin I- and angiotensin II-induced hypertension in Wistar rats

2015

Novel peptides with antihypertensive effects in SHR rats have previously been identified in lactoferrin (LF) hydrolysates. To investigate their in vivo antihypertensive mechanism, we have assessed the blood pressure lowering effects of two of these LF-derived peptides (RPYL and DPYKLRP) in Wistar rats subjected to either angiotensin I- or angiotensin II-induced hypertension. Blood pressure was measured by the tail-cuff method, hypertension was induced by subcutaneous infusion of angiotensins, and then captopril, valsartan or LF-derived peptides orally administered. Angiotensin I- and angiotensin II-induced hypertension were reversed by captopril and valsartan, respectively. RPYL and DPYKLRP…

medicine.medical_specialtyMedicine (miscellaneous)Lactoferrin-derived peptidesPharmacologyWistar ratAntihypertensive peptidesInternal medicineRenin–angiotensin systemMedicineTX341-641Angiotensin-induced hypertensionNutrition and DieteticsAngiotensin II receptor type 1biologyNutrition. Foods and food supplybusiness.industryCaptoprilAngiotensin-converting enzymeAngiotensin IIBlood pressureEndocrinologyValsartanbiology.proteinRenin angiotensin systemmedicine.symptombusinessVasoconstrictionFood Sciencemedicine.drugIn vivo ACE inhibition
researchProduct

2019

OBJECTIVE With a combination of different sympathetic tests, we aimed to elucidate whether impairment of sympathetic function in Parkinson's disease (PD) is the consequence of a central or peripheral efferent dysfunction. METHODS Thirty-five patients with early-to-intermediate PD (median age: 63 years; IQR: 57-67 years; disease duration 1-9 years, 15 women) and 20 age- and sex-matched healthy controls (median age: 64.5 years; IQR: 58-68 years; 10 women) were recruited. Autonomic testing was performed in two subgroups and included the assessment of resting cardiovascular parameters, postprandial hypotension (PPH), orthostatic hypotension (OH), and vasoconstriction induced by intradermal micr…

medicine.medical_specialtyMicrodialysisParkinson's diseasebusiness.industry05 social sciencesMicroneurographymedicine.disease050105 experimental psychology03 medical and health sciencesBehavioral NeuroscienceOrthostatic vital signsNorepinephrine0302 clinical medicineBlood pressureInternal medicinemedicineCardiology0501 psychology and cognitive sciencesmedicine.symptomPure autonomic failurebusiness030217 neurology & neurosurgeryVasoconstrictionmedicine.drugBrain and Behavior
researchProduct

Bronchodilator and anti-inflammatory activities of SCA40: studies in human isolated bronchus, human eosinophils, and in the guinea-pig in vivo.

1998

There is currently interest in the use of inhibitors of cyclic nucleotide phosphodiesterases (PDE) as potential anti-asthma agents. In this study we examined the effects of SCA40 (6-bromo-8-methylaminoimidazol-[1,2-a] pyrazine-2-carbonitrile), a preferential inhibitor of PDE 3 also endowed with PDE 4 and 5 inhibitory activities, on isolated bronchus and eosinophil functions and in an animal model of asthma. SCA40 (1 nM-0.1 mM) produced concentration-dependent inhibition of spontaneous and stimulated tone of human isolated bronchus and reached a maximal relaxation similar to that of theophylline (3 mM). The potency (-log EC50 values) of SCA40 against spontaneous tone (6.52 +/- 0.10) was grea…

medicine.medical_specialtyMuscle RelaxationGuinea PigsBronchiIn Vitro Techniqueschemistry.chemical_compoundIn vivoInternal medicinemedicineAnimalsHumansTheophyllineAntigensRolipramPharmacologyLeukotrieneLeukotriene C4Anti-Inflammatory Agents Non-SteroidalImidazolesMuscle SmoothGeneral MedicineEosinophilLeukotriene C4Bronchodilator AgentsEosinophilsmedicine.anatomical_structureEndocrinologychemistryPyrazinesBronchoconstrictionmedicine.symptomBronchial HyperreactivityHistaminemedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Ca2+ entry blockers inhibit prostaglandin F2 alpha-induced cerebrovascular contractile responses in goats.

1991

We examined the effects of extracellular Ca2+ withdrawal and of Ca2+ entry blockers on goat cerebrovascular responses to prostaglandin F2 alpha (PGF2 alpha). We measured isometric tension in isolated middle cerebral arteries, and cerebral blood flow (CBF) in unanesthetized animals. PGF2 alpha produced concentration-dependent contractions of isolated arteries. The contractions were partially inhibited by incubation in Ca(2+)-free medium (by 63.1 +/- 1.8% without ethyleneglycol-bis-(beta-amino-ethylether)-N,N,N',N'-tetra-a cetate (EGTA), and by 82.4 +/- 3.7% with EGTA). The Ca2+ entry blockers inhibited PGF2 alpha-elicited contraction and relaxed PGF2 alpha-precontracted arteries (nicardipine…

medicine.medical_specialtyMuscle RelaxationNicardipineCerebral arteriesProstaglandinIn Vitro TechniquesDinoprostCerebral circulationchemistry.chemical_compoundInternal medicinemedicine.arteryIsometric ContractionmedicineAnimalsNimodipineEgtazic AcidPharmacologyGoatsCerebral ArteriesCalcium Channel BlockersEndocrinologychemistryVasoconstrictionCerebrovascular CirculationCirculatory systemMiddle cerebral arteryVerapamilCalciumFemalemedicine.drugEuropean journal of pharmacology
researchProduct

The Spanish Pancreatic Club's recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment).

2012

Chronic pancreatitis (CP) is a complex disease with a wide range of clinical manifestations. This range comprises from asymptomatic patients to patients with disabling symptoms or complications. The management of CP is frequently different between geographic areas and even medical centers. This is due to the paucity of high quality studies and clinical practice guidelines regarding its diagnosis and treatment. The aim of the Spanish Pancreatic Club was to give current evidence-based recommendations for the management of CP. Two coordinators chose a multidisciplinary panel of 24 experts on this disease. These experts were selected according to clinical and research experience in CP. A list o…

medicine.medical_specialtyPancreatic pseudocystEndocrinology Diabetes and MetabolismExocrine pancreatic insufficiencyMEDLINENutritional StatusDiseaseConstriction PathologicGuidelinesPancreatitis ChronicPancreatic PseudocystDiagnosismedicinePain ManagementPancreatitis chronicIntensive care medicineExocrine pancreatic insufficiencyAcetaminophenCholangiopancreatography Endoscopic RetrogradeEvidence-Based MedicineHepatologybusiness.industryAnti-Inflammatory Agents Non-SteroidalGastroenterologyEvidence-based medicinemedicine.diseaseSurgeryPancreatic fistulaPancreatitisDrainageExocrine Pancreatic InsufficiencyTherapybusiness
researchProduct

Comparing the Outcomes of Different Agents to Treat Vasospasm at Microsurgical Anastomosis during the Papaverine Shortage.

2017

Letter to Editor

medicine.medical_specialtyPapaverinemicrosurgery anastomosisbusiness.industryVasodilator AgentsSettore MED/19 - Chirurgia PlasticaMEDLINEEconomic shortageVasospasmmedicine.diseaseMicrosurgical anastomosisSurgery030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineVasodilator agentsVasoconstriction030220 oncology & carcinogenesisPapaverinemedicineHumansSurgeryVascular Diseasesbusinessmedicine.drugPlastic and reconstructive surgery
researchProduct

Methylene blue-aided cholangioscopy in patients with biliary strictures: feasibility and outcome analysis

2008

BACKGROUND AND STUDY AIMS: Chromoendoscopy using methylene blue is employed in the gastrointestinal tract to delineate neoplastic lesions. We tested the value of chromoendoscopy during choledochoscopy for characterization of local inflammation, neoplasias, and other alterations in patients with biliary strictures. METHODS: Patients with suspected biliary lesions were scheduled for endoscopic retrograde cholangiography with subsequent cholangioscopy. After initial inspection of the bile duct, 15 ml methylene blue (0.1 %) was administered via the working channel of the cholangioscope. Newly appearing circumscribed or unstained lesions were judged according to their macroscopic type and staini…

medicine.medical_specialtyPathologybusiness.industryBile ductGastroenterologyHistologyBile Duct DiseasesConstriction Pathologicmedicine.diseaseGastroenterologyPrimary sclerosing cholangitisStainingChromoendoscopyMethylene BlueStenosisTreatment Outcomemedicine.anatomical_structureCholestasisDysplasiaInternal medicinemedicineFeasibility StudiesHumansEndoscopy Digestive SystembusinessEndoscopy
researchProduct

Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options

2010

Asthma is a chronic inflammatory disorder of the airways that requires long-term treatment, the goal of which is to control clinical symptoms for extended periods with the least possible amount of drugs. International guidelines recommend the addition of an inhaled long-acting beta2-agonist (LABA) to a low- to medium-dose inhaled corticosteroid (ICS) when low doses of ICS fail to control asthma symptoms. The fixed combined administration of ICS/LABA improves patient compliance, reducing the risk of therapy discontinuation. The relative deposition pattern of the inhaled drug to the target site is the result of a complex interaction between the device used, the aerosol formulation and the pat…

medicine.medical_specialtyPathologymedicine.drug_classMedicine (miscellaneous)ReviewSettore MED/10 - Malattie Dell'Apparato Respiratoriocompliancedevice treatment inhalers complianceMedicineinhalersIntensive care medicinePharmacology Toxicology and Pharmaceutics (miscellaneous)Asthmatherapybusiness.industryHealth PolicyTreatment optionsAsthma symptomsasthmamedicine.diseaseChronic inflammatory disorderDiscontinuationCorticosteroidBronchoconstrictionFormoterolmedicine.symptombusinessSocial Sciences (miscellaneous)medicine.drugPatient Preference and Adherence
researchProduct

Perkutane Implantation einer endovaskulären Gianturco-Prothese bei V.-subclavia-Verschluß

1989

Observation d'une femme de 72 ans, hemodialysee, avec œdeme croissant du bras portant le shunt. L'obliteration de la veine sous-claviere a ete traitee par fibrinolyse locale, dilatation et prothese de Gianturco

medicine.medical_specialtyPercutaneousbusiness.industrymedicine.medical_treatmentRadiographyProsthesisSurgeryConstrictionBlood vessel prosthesisAngioplastymedicineRadiology Nuclear Medicine and imagingbusinessSubclavian veinRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Rolipram inhibits airway microvascular leakage induced by platelet-activating factor, histamine and bradykinin in guinea-pigs.

1993

Abstract Rolipram (0·1–1000 μg kg−1, i.v.) reduced the increase in microvascular permeability induced by platelet-activating factor (PAF; 50 ng kg−1, i.v.) at different sites of the guinea-pig airways. Rolipram (1–100μg kg−1, i.v.) inhibited histamine (30μg kg−1, i.v.)-and bradykinin (0·3 μg kg, i.v.)-induced airway microvascular leakage. These effects of rolipram were obtained at doses which inhibit histamine (7–20 μg kg−1 min−1)-induced bronchoconstriction (IC50 = 3 ± 1 μg kg, i.v.) without depressing arterial blood pressure in the guinea-pig. Aminophylline (50 mg kg−1) did not change the effect of PAF. The anti-exudative effect of rolipram is of potential therapeutic value in asthma.

medicine.medical_specialtyPhosphodiesterase InhibitorsGuinea PigsPharmaceutical ScienceBradykininVascular permeabilityBlood PressureBronchiBradykininCapillary Permeabilitychemistry.chemical_compoundInternal medicinemedicineAnimalsDrug InteractionsPlatelet Activating FactorRolipramPharmacologyPlatelet-activating factorMicrocirculationAminophyllinePyrrolidinonesTracheaEndocrinologymedicine.anatomical_structurechemistryBronchoconstrictionAminophyllinemedicine.symptomRolipramHistaminemedicine.drugBlood vesselEvans BlueHistamineThe Journal of pharmacy and pharmacology
researchProduct